Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type
- 1 March 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 74 (3) , 382-388
- https://doi.org/10.1016/0002-9343(83)90955-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapyBlood, 1982
- Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapyCancer, 1981
- Cyclophosphamide, Vincristine, Methotrexate with Leucovorin Rescue, and Cytarabine (COMLA) Combination Sequential Chemotherapy for Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1980
- Factors Predicting for Response and Survival in Adults With Advanced Non-Hodgkin's LymphomaArchives of internal medicine (1960), 1978
- Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapyThe American Journal of Medicine, 1977
- Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphomaBlood, 1977
- COMBINATION CHEMOTHERAPY OF ADVANCED NON-HODGKIN LYMPHOMA WITH BLEOMYCIN, ADRIAMYCIN, CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE (BACOP)1977
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- Bleomycin, Adriamycin, Cyclophosphamide, Vincristine, and Prednisone (BACOP) Combination Chemotherapy in the Treatment of Advanced Diffuse Histiocytic LymphomaAnnals of Internal Medicine, 1976